Starling Oncology, Inc.
Research Starling Oncology, Inc. (STLN) on Bullrun: market cap USD 646.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTLN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Market capUSD 646.02M
- Financial periodQ2 2026
- RevenueUSD 161.28M
- Net income-USD 9.79M
- Free cash flowUSD 11.03M
- Gross margin16.8%
Valuation Snapshot
latest market cap is USD 646.02M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 502.73M | -USD 60.61M | -USD 27.79M | 15.2% | -0.54 | USD 33.57M | USD 103.69M | -USD 15.72M |
| FY2024 | USD 393.41M | -USD 64.66M | -USD 30.33M | 13.7% | -0.71 | USD 49.67M | USD 123.15M | USD 3.59M |
| FY2023 | USD 324.24M | -USD 83.07M | -USD 40.88M | 18.4% | -0.92 | USD 33.49M | USD 119.68M | USD 57.03M |
| FY2022 | USD 252.48M | USD 152.00K | -USD 67.29M | 20.6% | -0.2 | USD 14.01M | USD 108.18M | USD 123.18M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 646.02M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 351.95M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 23.40M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 150.41M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 119.36M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 714.18M | n/a | n/a | n/a |
About Starling Oncology, Inc.
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Starling Oncology, Inc.'s market cap?
Starling Oncology, Inc.'s market capitalization is USD 646.02M.
What does Starling Oncology, Inc. do?
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.